Precision BioSciences, Inc. IPO Research Information

Precision BioSciences, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Precision BioSciences, Inc. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Precision BioSciences, Inc.	DTIL - NASDAQ	$15.00-$17.00	$16.00	$18.00	7.9 million	3/28/2019
Underwriter(s): J.P. Morgan, Goldman Sachs & Co., Jefferies, Barclays
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2019-03-01 Terms Added 2019-03-18

Precision BioSciences, Inc. Quote & Chart - Click for current quote - DTIL

About Precision BioSciences, Inc. (adapted from Precision BioSciences, Inc. prospectus):
They are a genome editing company dedicated to improving life through our groundbreaking proprietary genome editing platform, "ARCUS".

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "DTIL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.